Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 16/20 | 0.57 |
| ▸ | TAS1R1 | Q7RTX1 | 16/20 | 0.57 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.39 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.39 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.39 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.39 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.39 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.39 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL447540 | 0.92 | TAS1R3 (0.60) | TAS1R3TAS1R1HDAC3HDAC1HDAC2 | |
| SCHEMBL4255578 | 0.88 | TAS1R3 (0.49) | TAS1R3TAS1R1 | |
| SCHEMBL4250954 | 0.88 | TAS1R3 (0.66) | TAS1R3TAS1R1HDAC3HDAC1HDAC2 | |
| SCHEMBL4251053 | 0.86 | TAS1R3 (0.62) | TAS1R3TAS1R1LMNAALDH1A1GAA | |
| SCHEMBL4254278 | 0.83 | HPGD (0.53) | TAS1R3TAS1R1HDAC3HDAC1HDAC2 | |
| SCHEMBL4252461 | 0.83 | TAS1R3 (0.50) | TAS1R3TAS1R1LMNAGAA | |
| SCHEMBL4429988 | 0.81 | TAS1R3 (0.56) | TAS1R3TAS1R1HDAC3HDAC1HDAC2 | |
| SCHEMBL4248654 | 0.81 | TAS1R3 (0.47) | TAS1R3TAS1R1 | |
| SCHEMBL4255359 | 0.80 | TAS1R3 (0.52) | TAS1R3TAS1R1HDAC3HDAC1HDAC2 | |
| SCHEMBL447778 | 0.80 | TAS1R3 (0.52) | TAS1R3TAS1R1HDAC3HDAC1HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090023798-A1 | THIOHYDROXAMATES AS INHIBITORS OF HISTONE DEACETYLASE | PHARMACYCLICS, INC. (US) | 2009-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090023798-A1 | THIOHYDROXAMATES AS INHIBITORS OF HISTONE DEACETYLASE | HDAC1, HDAC8, HDAC3 | TAS1R3 3722/4885TAS1R1 3753/4885HDAC3 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.